Abstract
Although the presence of SARS-CoV-2 fragments in raw sewage water are not much concerning, since it is a new pathogen and its fate in the environment is poorly understood; therefore efforts are needed for their effective removal. In under-developed countries with poor sewersheds and sanitation practices, the raw sewage water might come in contact with rivers and other water bodies and is generally used by the population for various purposes including drinking water. Hence it is important to properly treat sewage water to reduce public health risks, if any. Our study evaluated various advanced oxidation processes (AOPs) for disinfection of SARS-CoV-2 from sewage water collected from the academic institutional residential campus. The present study is the first report showing hydrodynamic cavitation (HC) used to reduce the SARS-CoV-2 viral load from sewage water. Additionally, we have also evaluated hybrid techniques like HC/O3, HC/O3/H2O2, HC/H2O2, O3/UV, UV/H2O2, UV/H2O2/O3, and O3/H2O2 for the minimization of the SARS-CoV-2 viral load from sewage water. The sewage water treatment techniques were evaluated based on its viral concentration-reducing efficiency by comparing it with the same raw sewage water sample. However, ozone alone and its combination with other disinfecting techniques (like HC, UV, and H2O2) showed >95% SARS-CoV-2 specific RNA-reducing efficiency (also known as viral load). The AOPs treated sewage water was subjected to total nucleic acid isolation followed by RT-qPCR for viral load estimation. Interestingly, all sewage water treatment techniques used in this study significantly reduces both the SARS-CoV-2 viral load as well as PMMoV (faecal indicator) load.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work funded by CSIR through project E3OW (MLP102326B) and National Chemical Laboratory, Pune (MLP 038526).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
